These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

836 related articles for article (PubMed ID: 32066847)

  • 1. The effects of a multispecies synbiotic on microbiome-related side effects of long-term proton pump inhibitor use: A pilot study.
    Horvath A; Leber B; Feldbacher N; Steinwender M; Komarova I; Rainer F; Blesl A; Stadlbauer V
    Sci Rep; 2020 Feb; 10(1):2723. PubMed ID: 32066847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis.
    Horvath A; Rainer F; Bashir M; Leber B; Schmerboeck B; Klymiuk I; Groselj-Strele A; Durdevic M; Freedberg DE; Abrams JA; Fickert P; Stiegler P; Stadlbauer V
    Sci Rep; 2019 Aug; 9(1):12000. PubMed ID: 31427714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a multispecies synbiotic on glucose metabolism, lipid marker, gut microbiome composition, gut permeability, and quality of life in diabesity: a randomized, double-blind, placebo-controlled pilot study.
    Horvath A; Leber B; Feldbacher N; Tripolt N; Rainer F; Blesl A; Trieb M; Marsche G; Sourij H; Stadlbauer V
    Eur J Nutr; 2020 Oct; 59(7):2969-2983. PubMed ID: 31729622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing proton pump inhibitors with histamin-2 receptor blockers regarding the risk of osteoporotic fractures: a nested case-control study of more than 350,000 Korean patients with GERD and peptic ulcer disease.
    Park JH; Lee J; Yu SY; Jung JH; Han K; Kim DH; Rhee J
    BMC Geriatr; 2020 Oct; 20(1):407. PubMed ID: 33059626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pantoprazole: a proton pump inhibitor with oral and intravenous formulations.
    Devault KR
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):197-205. PubMed ID: 19072410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proton Pump Inhibitors and their Microbiome-Mediated Side Effects].
    Horvath A; Stadlbauer V
    Zentralbl Chir; 2021 Apr; 146(2):165-169. PubMed ID: 33327006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitor-induced gut dysbiosis and immunomodulation: current knowledge and potential restoration by probiotics.
    Kiecka A; Szczepanik M
    Pharmacol Rep; 2023 Aug; 75(4):791-804. PubMed ID: 37142877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effect of probiotics supplements in reflux esophagitis treated with esomeprazole: A randomized controlled trial.
    Sun QH; Wang HY; Sun SD; Zhang X; Zhang H
    World J Gastroenterol; 2019 May; 25(17):2110-2121. PubMed ID: 31114137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised clinical trial: daily pantoprazole magnesium 40 mg vs. esomeprazole 40 mg for gastro-oesophageal reflux disease, assessed by endoscopy and symptoms.
    Moraes-Filho JP; Pedroso M; Quigley EM;
    Aliment Pharmacol Ther; 2014 Jan; 39(1):47-56. PubMed ID: 24299323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Proton pump inhibitors (PPI): may be not as harmless as believed].
    Reinberg O
    Rev Med Suisse; 2015 Sep; 11(485):1665-71. PubMed ID: 26540997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 40 mg pantoprazole and 40 mg esomeprazole are equivalent in the healing of esophageal lesions and relief from gastroesophageal reflux disease-related symptoms.
    Gillessen A; Beil W; Modlin IM; Gatz G; Hole U
    J Clin Gastroenterol; 2004 Apr; 38(4):332-40. PubMed ID: 15087692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug fever due to a single dose of pantoprazole.
    Schiller D; Maieron A; Schöfl R; Donnerer J
    Pharmacology; 2014; 94(1-2):78-9. PubMed ID: 25228460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of Enterogermina's Protective and Restorative Mechanisms on the Gut Microbiota with PPI, Using SHIME Technology.
    Duysburgh C; Verstrepen L; Broeck MVD; Righetto Z; Perez M
    Nutrients; 2023 Jan; 15(3):. PubMed ID: 36771360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of gastric acid suppression on probiotic colonization in a double blinded randomized clinical trial.
    Singh G; Haileselassie Y; Briscoe L; Bai L; Patel A; Sanjines E; Hendler S; Singh PK; Garud NR; Limketkai BN; Habtezion A
    Clin Nutr ESPEN; 2022 Feb; 47():70-77. PubMed ID: 35063245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of diet and synbiotics on selected gut bacteria and intestinal permeability in individuals with excess body weight - A Prospective, Randomized Study.
    Janczy A; Aleksandrowicz-Wrona E; Kochan Z; Małgorzewicz S
    Acta Biochim Pol; 2020 Dec; 67(4):571-578. PubMed ID: 33326198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Proton Pump Inhibitor Withdrawal on Dabigatran Etexilate Plasma Levels in Patients With Atrial Fibrillation: A Washout Study.
    Schnierer M; Samoš M; Bolek T; Škorňová I; Nosáková L; Bánovčin P; Galajda P; Stasko J; Kubisz P; Hyrdel R; Mokáň M
    J Cardiovasc Pharmacol; 2020 Apr; 75(4):333-335. PubMed ID: 31895873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND study.
    Kinoshita Y; Kato M; Fujishiro M; Masuyama H; Nakata R; Abe H; Kumagai S; Fukushima Y; Okubo Y; Hojo S; Kusano M
    J Gastroenterol; 2018 Jul; 53(7):834-844. PubMed ID: 29188387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactobacillus paracasei F19 versus placebo for the prevention of proton pump inhibitor-induced bowel symptoms: a randomized clinical trial.
    Compare D; Rocco A; Sgamato C; Coccoli P; Campo SM; Nazionale I; Larussa T; Luzza F; Chiodini P; Nardone G
    Dig Liver Dis; 2015 Apr; 47(4):273-9. PubMed ID: 25660822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Microbiota Composition Before and After Use of Proton Pump Inhibitors.
    Hojo M; Asahara T; Nagahara A; Takeda T; Matsumoto K; Ueyama H; Matsumoto K; Asaoka D; Takahashi T; Nomoto K; Yamashiro Y; Watanabe S
    Dig Dis Sci; 2018 Nov; 63(11):2940-2949. PubMed ID: 29796911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the Intestinal Microbiome during a Multispecies Probiotic Intervention in Compensated Cirrhosis.
    Horvath A; Durdevic M; Leber B; di Vora K; Rainer F; Krones E; Douschan P; Spindelboeck W; Durchschein F; Zollner G; Stauber RE; Fickert P; Stiegler P; Stadlbauer V
    Nutrients; 2020 Jun; 12(6):. PubMed ID: 32585997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.